Feed NAOV
NA

NanoVibronix, Inc.

NAOV · NASDAQ

$1.90 +1.06% (+$0.02)
Piotroski F-Score Weak
0/9
Valuation
-
N/A
P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A
FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A
Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A
ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A
Debt/Assets N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
0 /100
Unstable
Beta 2.06x
Profitable years N/A
Rev. volatility N/A

Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe

Întreabă StockBot despre NAOV
Online

Despre companie

NanoVibronix (NVCN) is a company focused on the development and commercialization of innovative medical devices utilizing ultrasound technology. With a product portfolio including PainShield®, NanoVibronix is a pioneer in the field of ultrasound therapy for the treatment of various conditions and ailments. PainShield® is a portable device designed to treat pain and inflammation using ultrasound vibrations applied to the affected area. The company also focuses on other applications of ultrasound technology in areas such as regenerative therapies, drainage procedures, and infection prevention. With growing interest in non-invasive therapeutic methods and the need for innovative treatment approaches, NanoVibronix has the potential for further development and expansion in the market. NanoVibronix (NVCN) shares could be suitable for investors seeking exposure in the medical technology field with a focus on ultrasound therapy and innovative treatment approaches.

Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.

Sector

Healthcare

Industry

Medical - Devices

CEO

Doron Robert Besser

Employees

31

Headquarters

Elmsford

Folosim cookie-uri esențiale pentru funcționarea site-ului și cookie-uri analitice opționale pentru a măsura utilizarea. Consultați Politica de confidențialitate.